INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45m ago
House PTR4m ago
SEC 13F4m ago
Robinhood Chain4m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$12K
2,376 sh
Apr 7, 2026Apr 8, 2026
Page 997 of 1737
← PrevNext →
traded Apr 7, 2026
+1d
SEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$12K
2,424 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$5,016
1,030 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,597 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$12K
2,400 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,600 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

16
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$12K
2,520 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

16
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$72K
3,970 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,700 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$12K
2,400 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,700 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$12K
2,500 sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,705 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Tax withholding
F$496K
6,920 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
CS
Cutler ScottDirector, President and CEO
HQYHEALTHEQUITY, INC.
Tax withholding
F$413K
4,931 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
PA
Pardo AvitalDirector, Deputy Chief Executive Officer
PGYPagaya Technologies Ltd.
Grant or award
A—
185.0K sh
Apr 1, 2026Apr 8, 2026
traded Apr 1, 2026
+7dSEC Form 4

Evidence

15
LM
Lucania James MEVP & CFO
HQYHEALTHEQUITY, INC.
Tax withholding
F$368K
4,393 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Grant or award
A$879K
12.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Grant or award
A$879K
12.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
YY
Yulzari YahavDirector, Deputy Chief Executive Officer
PGYPagaya Technologies Ltd.
Grant or award
A—
185.0K sh
Apr 1, 2026Apr 8, 2026
traded Apr 1, 2026
+7dSEC Form 4

Evidence

15
RM
Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN
NTRANatera, Inc.
Option exercise
M$559K
58.3K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
TH
Train Michael H.SVP & Chief Sustain Officer
EMREMERSON ELECTRIC CO
Tax withholding
F$696K
5,286 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Tax withholding
F$482K
6,716 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
DS
Das SanjivPresident
PGYPagaya Technologies Ltd.
Grant or award
A—
200.0K sh
Apr 1, 2026Apr 8, 2026
traded Apr 1, 2026
+7dSEC Form 4

Evidence

15
RE
Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER
HQYHEALTHEQUITY, INC.
Tax withholding
F$400K
4,768 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Grant or award
A$905K
12.6K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

15
KG
Krubiner GalDirector, Chief Executive Officer
PGYPagaya Technologies Ltd.
Grant or award
A—
185.0K sh
Apr 1, 2026Apr 8, 2026
traded Apr 1, 2026
+7dSEC Form 4

Evidence

15
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Tax withholding
F$482K
6,716 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
BK
Boone KarenDirector
CRWVCoreWeave, Inc.
Option exercise
M—
1,460 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
DM
David MosheDirector
KDOZFKIDOZ INC.
Expiration of short derivative
E$41K
50.0K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
WR
Wilson Lance RobertChief Financial Officer
IDAIT Stamp Inc
Option exercise
M—
1,780 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
WR
Wilson Lance RobertChief Financial Officer
IDAIT Stamp Inc
Tax withholding
F$1,607
618 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
FS
Francis Andrew ScottChief Technology Officer
IDAIT Stamp Inc
Tax withholding
F$25K
9,628 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$97K
2,357 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
ME
Mark Martin EliasCFO
GAMBGRANDSTAND Ltd
Option exercise
M—
11.5K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
MW
McClintock WilliamDirector
IDAIT Stamp Inc
Option exercise
M—
52 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence

13
WR
Wilson Lance RobertChief Financial Officer
IDAIT Stamp Inc
Tax withholding
F$1,027
395 sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC Form 4

Evidence